Mounting Evidence Supporting Neoadjuvant ChemoIO Means Surgeons Must Adapt

More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care

A New Treatment Option for Early-Stage ALK+ NSCLC: Adjuvant Alectinib

Patient Perspective: Patients With EGFR+ NSCLC May Still Opt for Quality Over Quantity After FLAURA2

Transporting Real-World Evidence Between Countries—Ready to Beam Aboard?

Proposed Criteria for Tumor Invasion Align with Clinical Factors, Offer Better Predictability, Study Finds

Modified Lung Cancer Screening Eligibility Requirements May Reduce Racial Disparities in Lung Cancer Screening, Treatment

Mesothelioma Patients Experienced Higher Levels of Toxicity on CheckMate743 Regimen Than Reported in Clinical Trials

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

Patterns of Failure after PACIFIC: How to Address Disease Recurrence after Chemoradiotherapy and Immunotherapy

Artificial Intelligence in Thoracic Radiation Oncology: Patient Evaluation and Treatment Planning

Guideline Taskforce Chairs Discuss Need for Caution, Multidisciplinary Decision-Making When Using Definitive Radiotherapy for Oligometastatic NSCLC